Recruitment

Recruitment Status
Active, not recruiting
Estimated Enrollment
3120

Summary

Conditions
Diabetes Mellitus - Type 2
Type
Interventional
Phase
Phase 3
Design
Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Masking Description: Sponsor staff involved in the clinical trial is masked according to company standard proceduresPrimary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT03819153
Collaborators
Not Provided
Investigators
Study Director: Clinical Transparency (dept. 1452) Novo Nordisk A/S